Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a new study.
Regular testing and treatment of preschool children for snail fever -- known as schistosomiasis or bilharzia -- would reduce the spread of the disease, while promoting childhood health and development, experts have found.
The parasite, which is carried by freshwater snails, mainly infects people in sub-Saharan Africa. Once diagnosed, treatment with a cheap, readily available drug is usually effective.
Common symptoms include abdominal pain or blood in the urine. In children, it can cause stunted growth and learning difficulties. Infection acquired in childhood can cause bladder cancer and liver damage, or impact on reproductive health, in adults.
Until now, pre-school children have not been routinely tested for nor treated for the condition, as the health impact of childhood infection has not been well understood.
In the first long-term study of the disease in this age group, researchers at the University of Edinburgh and collaborators in Zimbabwe monitored 1500 children aged from 6 months to 5 years old over the course of a year.
Their research showed that children could contract an infection within their first year of life, and develop symptoms within three months. The study also highlighted for the first time that infected children are at risk of malnutrition and stunted growth. Treatment of the infection with the drug Praziquantel, was shown to reverse symptoms.
The study, funded by Wellcome and Thrasher Research Fund, was published in the BMJ Global Health.
Professor Francisca Mutapi of the University of Edinburgh's School of Biological Sciences, who led the study, said, "We now know there is no such thing as snail fever without symptoms, and young children can get infected by snail fever very early in their lives."
Derick Osakunor, of the University of Edinburgh's School of Biological Sciences, who took part in the project, commented, "Our findings show that young children can develop clinical disease quickly, but existing diagnosis methods and treatments are effective in under-fives, which is welcome news for managing cases of infection in young children."
Source: University of Edinburgh
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.